Wall Street Punished the Wrong Number

Rocket Lab crushed it.

The company posted $234 million in Q2 sales. That's up 62% from a year ago — a new record by a wide gap.

And the stock fell 10% after hours.

Let me explain. Wall Street doesn't reward what you did. It punishes what you cost. Rocket Lab lost $0.08 per share — worse than the Street expected.

That miss sent shares from $80.04 to $72.04 after the bell.

But the headline loss hides a huge quarter.

Backlog hit $2.36 billion — up 137% in twelve months. The company signed over $1 billion in new deals in Q2 and the weeks since. That includes a $397 million Space Force contract to build and fly Flatellite tracking sats.

Gross margin came in at 36.1%, beating the company's own 33–35% target.

And Q3 revenue guidance landed at $250 to $265 million… another step up.

The growth is not the problem.

So why did Wall Street sell? Two things.

First, Neutron. Rocket Lab's medium-lift rocket — the one built to take on Falcon 9 — is running late. CEO Peter Beck told investors the window for a 2026 debut is "narrowing." He first pitched Neutron in 2021 with a 2024 target.

Then it slipped to 2025. Now… likely 2027.

I know what you're thinking. "If they keep pushing the date, can we trust the timeline?"

Fair point.

But look at what Rocket Lab built while Neutron waited. They closed the Mynaric deal for laser comms. They locked in an $8 billion merger with Iridium — adding a global comms network, scarce L-band spectrum, and 2.55 million paying subscribers.

In other words, Rocket Lab now builds rockets, makes satellites, and runs a constellation. One other company does all three. You know the name.

The second concern is cash.

Neutron eats capital. So does the Iridium buy. Rocket Lab lined up $3.6 billion in bridge loans to fund the deal. That's heavy debt for a company still posting losses.

It's a big bet.

But 90-plus missions sit in the launch backlog. Defense dollars keep flowing. And once Iridium closes in mid-2027, it adds $872 million in yearly revenue and a 57% EBITDA margin.

That turns Rocket Lab from a fast grower into a cash machine.

The market handed you a 10% discount. I'd take it.

Billionaire investors are already moving money to prepare for what’s coming…

Take a look at this…

It’s smaller than a fingertip…

It’s made of glass…

And it’s about to unlock the next wave of AI growth.

Jensen Huang, Nvidia's CEO, says this “light-speed” device is shattering the limitations of AI… and without it, AI can’t scale.

Google Ventures says it’s the future of AI compute...

And Sequoia Capital — the firm that backed Anthropic and OpenAI — calls it a “holy grail.”

Already, Elon Musk, Mark Zuckerberg, Cathie Wood, and Bill Gates are moving money to prepare for what’s coming…

Yet most Americans have never heard of it.

Wall Street insider Jason Bodner — the same man who called Nvidia at $4.50 — says this device is about to launch a whole new wave of AI winners…

And to prove it, he’s giving away his #1 stock involved with it — for free.

P.S. Stocks tied to this “light-speed” device already surged 133%, 217%, and even 320% — in a few short months. But it’s just getting started. Click here before the mainstream catches on.

Vertical, all the way. Rocket Lab framed the Iridium deal as the move that makes it a "self-launching, tier-1 space power" — one that designs, builds, launches, and operates its own constellation. Iridium brings a 66-satellite network, 2.5 million-plus subscribers, and steady profit. Beck flagged one near-term prize: positioning, navigation, and timing services, which Iridium's satellites could boost with modest tweaks. It also unlocks mission-critical government work Rocket Lab couldn't bid before. Watch the PNT push.

Proof in the field. On the Victus Hayes mission, Rocket Lab launched an Electron to orbit in a record 16 hours and 42 minutes, commissioned the satellite in 38 hours, and completed a tricky rendezvous with an uncooperative target in under 59 hours. For the military, that kind of speed is the whole point — responsive launch on demand. It's exactly the capability defense buyers keep funding. Execution like this is what backs the backlog. Watch for more rapid-response tasking.

The other side of the story. Rocket Lab ended Q2 with about $2.13 billion in cash, boosted by a stock-sale program that raised $1.08 billion before it was shut off. But free cash flow stays negative and elevated, driven by Neutron and factory scale-up. Management doesn't expect positive cash flow until 18 to 24 months after Neutron's first flight. Growth this fast isn't free. Watch the burn rate against the cash pile.

Everything now points to one event: Neutron's first flight.

Here's where it stands. Rocket Lab says the first-stage tank is targeting delivery to the launch pad in the fourth quarter of this year. But management admits the window to actually launch in 2026 is "narrowing." Read that as: likely slipping into 2027.

Why does this one rocket matter so much?

Because Neutron is Rocket Lab's answer to Falcon 9. Its small Electron rocket is proven but tiny. Neutron is the big, reusable vehicle meant to win heavy government and commercial launches. Without it, Rocket Lab can't fully compete for the largest jobs.

The riskiest step is still ahead. Beck singled out stage testing — the first time a fully fueled vehicle lights its engines — as the white-knuckle moment. As he put it, when that goes badly for other firms, it "really doesn't go well."

And the cash clock ties to it. The company doesn't expect positive free cash flow until 18 to 24 months after Neutron first flies. So every slip pushes profitability further out.

So watch the pad this quarter. The earnings are strong, the backlog is real, but Neutron is the milestone that turns the whole plan from promise into proof.

Let's keep this simple.

A stock price isn't about how a company did last quarter. It's about what people already expected. That gap — between the result and the expectation — is what moves the price.

Think of it like a school test.

Say everyone knows a top student will score 95. She scores 92. Still a great grade. But it's below what the class assumed. So people are a little let down, even though she aced it. The number was high; the surprise was negative.

That's what happened to Rocket Lab.

Revenue hit a record. Backlog soared. But the loss per share came in worse than Wall Street penciled in. And the big new rocket, Neutron, looks likely to slip again. So even with a stellar quarter, the surprises leaned negative.

Here's the deeper point. A young growth company is priced on the future, not the present. Investors have already baked in years of success. To push the stock higher, results must beat that lofty bar, not just look good on their own.

So a sell-off after great numbers isn't always a red flag. Often it's just expectations resetting. The business can be thriving while the stock takes a breather.

The trick is to separate the two. Ask whether the drop reflects a broken business, or just a high bar the company still has to grow into.

Follow the expectations, not just the earnings.